Wolie Zenaw T, Roberts Jason A, López-Cortés Luis Eduardo, Mirón-Rubio Manuel, Pollard James, Marizan Nor Afra Nahdia, Abdul-Aziz Mohd H, Jamieson Conor, Seaton R Andrew, Gilchrist Mark, Sime Fekade B
Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4029, Australia.
Department of Pharmacy, College of medicine and health Sciences, Debre Markos University, Debre Markos, Ethiopia.
JAC Antimicrob Resist. 2025 May 27;7(3):dlaf075. doi: 10.1093/jacamr/dlaf075. eCollection 2025 Jun.
This study aimed to assess the current international practices of outpatient parenteral antimicrobial therapy (OPAT).
A multi-site cross-sectional study was conducted, using REDCap platform for survey distribution and data collection. Data analysis was performed in SPSS version 29.
Of the 146 OPAT responding centres serving adults, paediatrics or both, 82% have been operating for over 10 years. OPAT teams were multidisciplinary, with nurses comprising the largest proportion in 89% of centres, followed by infectious disease (ID) pharmacists (83%) and ID physicians (80%). Service activity varied widely, with 92% centres treating fewer than 100-5000 patients annually (median = 300). Home-based models of care were used by more than 85% of facilities in Australia, the UK and Spain, while 82% of Malaysian and 75% of UK centres used infusion centres. Common OPAT indications include skin and soft tissue, bone and joint, urinary tract and respiratory tract infections, with ceftriaxone and ertapenem used by over 80% of the centres. Peripherally inserted central and midline catheters were common except in Malaysia. Among enrolled centres, complex oral antimicrobial therapy supervision was higher in the UK (82%) than in Spain (77%), Australia (42%) and Malaysia (24%). Inconsistencies in guidelines supporting antimicrobial stability and dosing information were noted, with a call for more stability data on certain antimicrobials.
This study revealed significant variation in OPAT practice. Further study is needed to understand the reasons for these differences and whether better alignment of practice could improve patient outcomes, antimicrobial stewardship practice and resource utilization.
本研究旨在评估目前门诊胃肠外抗菌治疗(OPAT)的国际实践情况。
开展了一项多中心横断面研究,使用REDCap平台进行调查分发和数据收集。数据分析采用SPSS 29版软件。
在146个为成人、儿童或两者提供服务的OPAT响应中心中,82%已运营超过10年。OPAT团队是多学科的,89%的中心护士占比最大,其次是传染病(ID)药剂师(83%)和ID医生(80%)。服务活动差异很大,92%的中心每年治疗的患者少于100 - 5000例(中位数 = 300)。澳大利亚、英国和西班牙超过85%的机构采用居家护理模式,而马来西亚82%的中心和英国75%的中心使用输液中心。常见的OPAT适应症包括皮肤和软组织、骨与关节、泌尿系统和呼吸道感染,超过80%的中心使用头孢曲松和厄他培南。除马来西亚外,外周静脉穿刺中心静脉导管和中线导管很常见。在纳入的中心中,英国(82%)复杂口服抗菌治疗的监管高于西班牙(77%)、澳大利亚(42%)和马来西亚(24%)。注意到在支持抗菌药物稳定性和给药信息的指南方面存在不一致,呼吁提供更多关于某些抗菌药物的稳定性数据。
本研究揭示了OPAT实践存在显著差异。需要进一步研究以了解这些差异的原因,以及实践的更好一致性是否可以改善患者结局、抗菌药物管理实践和资源利用情况。